U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208 books (719 items)

1.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

2.
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Harnan S, Kearns B, Scope A, et al.

Southampton (UK): National Institute for Health and Care Research; 2024 Oct. (Health Technology Assessment, No. 28.73.)

3.
Infectious Diseases of Mice and Rats.

Infectious Diseases of Mice and Rats.

National Research Council (US) Committee on Infectious Diseases of Mice and Rats.

Washington (DC): National Academies Press (US); 1991.

4.
Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide.

Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 71.)

5.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary.

Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2010.

6.
Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine.

Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States; Palmer GH, Buckley GJ, editors.

Washington (DC): National Academies Press (US); 2021 Oct 20.

7.
Endotext [Internet].

Endotext [Internet].

Feingold KR, Adler RA, Ahmed SF, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

8.
9.
Antimicrobial Drugs - Burden of Antimicrobial Resistance: Final Report [Internet].

Antimicrobial Drugs - Burden of Antimicrobial Resistance: Final Report [Internet].

Sertkaya A, McGeeney JD, Franz C, et al.

Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2022 Dec 26.

10.
Rapid molecular diagnostics for pathogen identification in hospital-acquired and ventilator-associated pneumonia in critical care: INHALE research programme including RCT.

Rapid molecular diagnostics for pathogen identification in hospital-acquired and ventilator-associated pneumonia in critical care: INHALE research programme including RCT.

Enne VI, Stewart SJF, Wagner AP, et al.

Southampton (UK): National Institute for Health and Care Research; 2026 Jun. (Programme Grants for Applied Research, No. 14.06.)

11.
Measures of Patient Safety Based on Hospital Administrative Data - The Patient             Safety Indicators.

Measures of Patient Safety Based on Hospital Administrative Data - The Patient Safety Indicators.

McDonald KM, Romano PS, Geppert J, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Aug. (Technical Reviews, No. 5.)

12.
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Woods B, Schmitt L, Jankovic D, et al.

Southampton (UK): National Institute for Health and Care Research; 2024 Jun. (Health Technology Assessment, No. 28.28.)

13.
Medical Microbiology. 4th edition.

Medical Microbiology. 4th edition.

Baron S, editor.

Galveston (TX): University of Texas Medical Branch at Galveston; 1996.

14.
Making Healthcare Safer III: A Critical Analysis of Existing and Emerging Patient Safety Practices [Internet].

Making Healthcare Safer III: A Critical Analysis of Existing and Emerging Patient Safety Practices [Internet].

Hall KK, Shoemaker-Hunt S, Hoffman L, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Mar.

15.
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.

Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.

Langton Hewer SC, Smyth AR, Brown M, et al.

Southampton (UK): NIHR Journals Library; 2021 Nov. (Health Technology Assessment, No. 25.65.)

16.
17.
Strengthening the EU response to prevention and control of Antimicrobial Resistance: Policy priorities for effective implementation [Internet].

Strengthening the EU response to prevention and control of Antimicrobial Resistance: Policy priorities for effective implementation [Internet].

Anderson M, Panteli D, Mossialos E.

Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2024. (Policy Brief, No. 63.)

19.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • Fig. 2.5
  • FIGURE WO-4-7
See more (6)...

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...